Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STEP-UP versus STEP-DOWN strategies in childhood arthritis
2018-001931-27Phase 3Active
- Sponsor
- Istituto Giannina Gaslini
- Start
- Oct 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of methotrexate and etanercept in juvenile idiopathic arthritis (JIA) (2 arms), sponsored by Istituto Giannina Gaslini. Primary endpoint: Inactive disease. Started Oct 2018; status: active.
02
Drugs
methotrexateetanercept
03
Conditions
juvenile idiopathic arthritis (JIA)
Beyond the preview
Go deeper on 2018-001931-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-001931-27.